lanifibranor • BioPharma Media

Lipaglyn: World’s First Drug to Treat Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease

Saroglitazar by Zydus Cadila has opened the doors to a new multi-billion dollar sector of NASH and NAFLD pharmacological treatments.